FETAL OUTCOMES IN PREGNANCIES COMPLICATED BY OLIGOHYDRAMNIOS- EXPERIENCE AT A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.52764/jms.23.31.3.4Keywords:
Oligohydramnios, Amniotic fluid, Cesarean section, Induction of labor, APGAR score, Perinatal outcomeAbstract
OBJECTIVE:
To find out the association between oligohydramnios and fetal outcome in terms of mode of delivery, the weight of the newborn baby, APGAR score at 1 and 5 minutes, and admission to the neonatology unit.
MATERIALS & METHODS: This prospective cohort study was conducted in Obstetrics and Gynaecology Department, Khyber Teaching Hospital, Peshawar from 1st June 2017 to 31st May 2018. Patients with singleton pregnancy and cephalic presentation with a period of gestation of about 37 weeks or above were included using a purposive non-probability sampling technique. A sample of 100 patients in Group A (exposed) whose AFI was < 5 in the absence of other associated risk factors were compared to 100 matched groups of subjects in Group B (non-exposed) with AFI 5—18. Pregnant women with gestational age <37 weeks, fetal congenital abnormalities, and pregnancies with co-morbidities like PIH, and pre-eclampsia were excluded from the study.
RESULTS: The result comparison shows that Group A has a higher rate of labor induction and cesarean section than Group B. However, there was no statistically significant difference in the weight of the newborn, APGAR score at 1 and 5 minutes, and admission to the neonatology unit in both groups.
CONCLUSION: Oligohydramnios is associated with a higher rate of induction of labor and cesarean section, but it does not affect the weight of newborn babies, APGAR score at 1 and 5 minutes, and admission of the newborn to the neonatology unit.
Key Words: Oligohydramnios, Amniotic fluid, Cesarean section, Induction of labor, APGAR score, Perinatal outcome.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Zubaida Akhtar, Fauzia Afridi, Saima Gilani
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
